Skip to content
Search

Latest Stories

Manns Pharmacy in Nottinghamshire sold to first-time buyer pair

Manns Pharmacy in Nottinghamshire sold to first-time buyer pair

The sale generated significant interest, with eight offers received from five different parties.

Specialist business property adviser, Christie & Co. has announced the sale of Manns Pharmacy, which is located in the residential area of Mapperley, Nottinghamshire.


According to the broker, the community pharmacy was dispensing an average of 5,000 items per month.

Gurinder Singh Mann, who owned the business for more than two decades, decided to put it on the market to allow him to retire.

After undergoing a discreet sales process, the pharmacy was acquired by a pair of first-time buyer friends, named Mitan Maisuria and Rahul Patel, for an undisclosed amount.

The new owners will be working together in the pharmacy going forward and they aim to increase its service offering, it said.

Carl Steer, Director – Pharmacy at Christie & Co, revealed that the sale generated significant interest, receiving eight offers from five different parties.

The funding for the purchase was sourced through David Ward, Senior Director at Christie Finance.

Ward expressed his delight in successfully arranging funding for Mitan and Rahul for the acquisition of Manns Pharmacy, especially considering the current lending market challenges compared to the same period last year.

He expressed confidence that the pair will take the pharmacy business to new levels.

As per the broker, the business was sold through an asset sale as a leasehold, but it didn’t disclose the transaction amount.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less